 Global Autoimmune Disease Drugs Market Growth 2026-2032
The global Autoimmune Disease Drugs market size is predicted to grow from US$ 144220 million in 2025 to US$ 185520 million in 2032; it is expected to grow at a CAGR of 3.7% from 2026 to 2032. Auto... もっと見る
図表リストList of TablesTable 1. Autoimmune Disease Drugs Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions) Table 2. Autoimmune Disease Drugs Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions) Table 3. Major Players of Biopharma Table 4. Major Players of Small Molecule Drug Table 5. Global Autoimmune Disease Drugs Sales by Type (2021-2026) & (K Units) Table 6. Global Autoimmune Disease Drugs Sales Market Share by Type (2021-2026) Table 7. Global Autoimmune Disease Drugs Revenue by Type (2021-2026) & ($ million) Table 8. Global Autoimmune Disease Drugs Revenue Market Share by Type (2021-2026) Table 9. Global Autoimmune Disease Drugs Sale Price by Type (2021-2026) & (US$/Unit) Table 10. Global Autoimmune Disease Drugs Sale by Application (2021-2026) & (K Units) Table 11. Global Autoimmune Disease Drugs Sale Market Share by Application (2021-2026) Table 12. Global Autoimmune Disease Drugs Revenue by Application (2021-2026) & ($ million) Table 13. Global Autoimmune Disease Drugs Revenue Market Share by Application (2021-2026) Table 14. Global Autoimmune Disease Drugs Sale Price by Application (2021-2026) & (US$/Unit) Table 15. Global Autoimmune Disease Drugs Sales by Company (2021-2026) & (K Units) Table 16. Global Autoimmune Disease Drugs Sales Market Share by Company (2021-2026) Table 17. Global Autoimmune Disease Drugs Revenue by Company (2021-2026) & ($ millions) Table 18. Global Autoimmune Disease Drugs Revenue Market Share by Company (2021-2026) Table 19. Global Autoimmune Disease Drugs Sale Price by Company (2021-2026) & (US$/Unit) Table 20. Key Manufacturers Autoimmune Disease Drugs Producing Area Distribution and Sales Area Table 21. Players Autoimmune Disease Drugs Products Offered Table 22. Autoimmune Disease Drugs Concentration Ratio (CR3, CR5 and CR10) & (2024-2026) Table 23. New Products and Potential Entrants Table 24. Market M&A Activity & Strategy Table 25. Global Autoimmune Disease Drugs Sales by Geographic Region (2021-2026) & (K Units) Table 26. Global Autoimmune Disease Drugs Sales Market Share Geographic Region (2021-2026) Table 27. Global Autoimmune Disease Drugs Revenue by Geographic Region (2021-2026) & ($ millions) Table 28. Global Autoimmune Disease Drugs Revenue Market Share by Geographic Region (2021-2026) Table 29. Global Autoimmune Disease Drugs Sales by Country/Region (2021-2026) & (K Units) Table 30. Global Autoimmune Disease Drugs Sales Market Share by Country/Region (2021-2026) Table 31. Global Autoimmune Disease Drugs Revenue by Country/Region (2021-2026) & ($ millions) Table 32. Global Autoimmune Disease Drugs Revenue Market Share by Country/Region (2021-2026) Table 33. Americas Autoimmune Disease Drugs Sales by Country (2021-2026) & (K Units) Table 34. Americas Autoimmune Disease Drugs Sales Market Share by Country (2021-2026) Table 35. Americas Autoimmune Disease Drugs Revenue by Country (2021-2026) & ($ millions) Table 36. Americas Autoimmune Disease Drugs Sales by Type (2021-2026) & (K Units) Table 37. Americas Autoimmune Disease Drugs Sales by Application (2021-2026) & (K Units) Table 38. APAC Autoimmune Disease Drugs Sales by Region (2021-2026) & (K Units) Table 39. APAC Autoimmune Disease Drugs Sales Market Share by Region (2021-2026) Table 40. APAC Autoimmune Disease Drugs Revenue by Region (2021-2026) & ($ millions) Table 41. APAC Autoimmune Disease Drugs Sales by Type (2021-2026) & (K Units) Table 42. APAC Autoimmune Disease Drugs Sales by Application (2021-2026) & (K Units) Table 43. Europe Autoimmune Disease Drugs Sales by Country (2021-2026) & (K Units) Table 44. Europe Autoimmune Disease Drugs Revenue by Country (2021-2026) & ($ millions) Table 45. Europe Autoimmune Disease Drugs Sales by Type (2021-2026) & (K Units) Table 46. Europe Autoimmune Disease Drugs Sales by Application (2021-2026) & (K Units) Table 47. Middle East & Africa Autoimmune Disease Drugs Sales by Country (2021-2026) & (K Units) Table 48. Middle East & Africa Autoimmune Disease Drugs Revenue Market Share by Country (2021-2026) Table 49. Middle East & Africa Autoimmune Disease Drugs Sales by Type (2021-2026) & (K Units) Table 50. Middle East & Africa Autoimmune Disease Drugs Sales by Application (2021-2026) & (K Units) Table 51. Key Market Drivers & Growth Opportunities of Autoimmune Disease Drugs Table 52. Key Market Challenges & Risks of Autoimmune Disease Drugs Table 53. Key Industry Trends of Autoimmune Disease Drugs Table 54. Autoimmune Disease Drugs Raw Material Table 55. Key Suppliers of Raw Materials Table 56. Autoimmune Disease Drugs Distributors List Table 57. Autoimmune Disease Drugs Customer List Table 58. Global Autoimmune Disease Drugs Sales Forecast by Region (2027-2032) & (K Units) Table 59. Global Autoimmune Disease Drugs Revenue Forecast by Region (2027-2032) & ($ millions) Table 60. Americas Autoimmune Disease Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 61. Americas Autoimmune Disease Drugs Annual Revenue Forecast by Country (2027-2032) & ($ millions) Table 62. APAC Autoimmune Disease Drugs Sales Forecast by Region (2027-2032) & (K Units) Table 63. APAC Autoimmune Disease Drugs Annual Revenue Forecast by Region (2027-2032) & ($ millions) Table 64. Europe Autoimmune Disease Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 65. Europe Autoimmune Disease Drugs Revenue Forecast by Country (2027-2032) & ($ millions) Table 66. Middle East & Africa Autoimmune Disease Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 67. Middle East & Africa Autoimmune Disease Drugs Revenue Forecast by Country (2027-2032) & ($ millions) Table 68. Global Autoimmune Disease Drugs Sales Forecast by Type (2027-2032) & (K Units) Table 69. Global Autoimmune Disease Drugs Revenue Forecast by Type (2027-2032) & ($ millions) Table 70. Global Autoimmune Disease Drugs Sales Forecast by Application (2027-2032) & (K Units) Table 71. Global Autoimmune Disease Drugs Revenue Forecast by Application (2027-2032) & ($ millions) Table 72. Qyuns Therapeutics Basic Information, Autoimmune Disease Drugs Manufacturing Base, Sales Area and Its Competitors Table 73. Qyuns Therapeutics Autoimmune Disease Drugs Product Portfolios and Specifications Table 74. Qyuns Therapeutics Autoimmune Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Qyuns Therapeutics Main Business Table 76. Qyuns Therapeutics Latest Developments Table 77. Bio-Thera Solutions Basic Information, Autoimmune Disease Drugs Manufacturing Base, Sales Area and Its Competitors Table 78. Bio-Thera Solutions Autoimmune Disease Drugs Product Portfolios and Specifications Table 79. Bio-Thera Solutions Autoimmune Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Bio-Thera Solutions Main Business Table 81. Bio-Thera Solutions Latest Developments Table 82. Hengrui Pharmaceuticals Basic Information, Autoimmune Disease Drugs Manufacturing Base, Sales Area and Its Competitors Table 83. Hengrui Pharmaceuticals Autoimmune Disease Drugs Product Portfolios and Specifications Table 84. Hengrui Pharmaceuticals Autoimmune Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Hengrui Pharmaceuticals Main Business Table 86. Hengrui Pharmaceuticals Latest Developments Table 87. Hisun Pharmaceutical Basic Information, Autoimmune Disease Drugs Manufacturing Base, Sales Area and Its Competitors Table 88. Hisun Pharmaceutical Autoimmune Disease Drugs Product Portfolios and Specifications Table 89. Hisun Pharmaceutical Autoimmune Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Hisun Pharmaceutical Main Business Table 91. Hisun Pharmaceutical Latest Developments Table 92. Sunshine Guojian Pharmaceutical Basic Information, Autoimmune Disease Drugs Manufacturing Base, Sales Area and Its Competitors Table 93. Sunshine Guojian Pharmaceutical Autoimmune Disease Drugs Product Portfolios and Specifications Table 94. Sunshine Guojian Pharmaceutical Autoimmune Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Sunshine Guojian Pharmaceutical Main Business Table 96. Sunshine Guojian Pharmaceutical Latest Developments Table 97. Chia Tai Tianqing Pharmaceutical Basic Information, Autoimmune Disease Drugs Manufacturing Base, Sales Area and Its Competitors Table 98. Chia Tai Tianqing Pharmaceutical Autoimmune Disease Drugs Product Portfolios and Specifications Table 99. Chia Tai Tianqing Pharmaceutical Autoimmune Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Chia Tai Tianqing Pharmaceutical Main Business Table 101. Chia Tai Tianqing Pharmaceutical Latest Developments Table 102. Chongqing Genrix Biopharmaceutical Basic Information, Autoimmune Disease Drugs Manufacturing Base, Sales Area and Its Competitors Table 103. Chongqing Genrix Biopharmaceutical Autoimmune Disease Drugs Product Portfolios and Specifications Table 104. Chongqing Genrix Biopharmaceutical Autoimmune Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Chongqing Genrix Biopharmaceutical Main Business Table 106. Chongqing Genrix Biopharmaceutical Latest Developments Table 107. Keymed Biosciences Basic Information, Autoimmune Disease Drugs Manufacturing Base, Sales Area and Its Competitors Table 108. Keymed Biosciences Autoimmune Disease Drugs Product Portfolios and Specifications Table 109. Keymed Biosciences Autoimmune Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Keymed Biosciences Main Business Table 111. Keymed Biosciences Latest Developments Table 112. Junshi Biosciences Basic Information, Autoimmune Disease Drugs Manufacturing Base, Sales Area and Its Competitors Table 113. Junshi Biosciences Autoimmune Disease Drugs Product Portfolios and Specifications Table 114. Junshi Biosciences Autoimmune Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Junshi Biosciences Main Business Table 116. Junshi Biosciences Latest Developments Table 117. Akeso Basic Information, Autoimmune Disease Drugs Manufacturing Base, Sales Area and Its Competitors Table 118. Akeso Autoimmune Disease Drugs Product Portfolios and Specifications Table 119. Akeso Autoimmune Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Akeso Main Business Table 121. Akeso Latest Developments Table 122. AbbVie Basic Information, Autoimmune Disease Drugs Manufacturing Base, Sales Area and Its Competitors Table 123. AbbVie Autoimmune Disease Drugs Product Portfolios and Specifications Table 124. AbbVie Autoimmune Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. AbbVie Main Business Table 126. AbbVie Latest Developments Table 127. AstraZeneca Basic Information, Autoimmune Disease Drugs Manufacturing Base, Sales Area and Its Competitors Table 128. AstraZeneca Autoimmune Disease Drugs Product Portfolios and Specifications Table 129. AstraZeneca Autoimmune Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. AstraZeneca Main Business Table 131. AstraZeneca Latest Developments Table 132. Biogen Basic Information, Autoimmune Disease Drugs Manufacturing Base, Sales Area and Its Competitors Table 133. Biogen Autoimmune Disease Drugs Product Portfolios and Specifications Table 134. Biogen Autoimmune Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 135. Biogen Main Business Table 136. Biogen Latest Developments Table 137. Bristol Myers Squibb Basic Information, Autoimmune Disease Drugs Manufacturing Base, Sales Area and Its Competitors Table 138. Bristol Myers Squibb Autoimmune Disease Drugs Product Portfolios and Specifications Table 139. Bristol Myers Squibb Autoimmune Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 140. Bristol Myers Squibb Main Business Table 141. Bristol Myers Squibb Latest Developments Table 142. Eli Lilly Basic Information, Autoimmune Disease Drugs Manufacturing Base, Sales Area and Its Competitors Table 143. Eli Lilly Autoimmune Disease Drugs Product Portfolios and Specifications Table 144. Eli Lilly Autoimmune Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 145. Eli Lilly Main Business Table 146. Eli Lilly Latest Developments Table 147. GlaxoSmithKline Basic Information, Autoimmune Disease Drugs Manufacturing Base, Sales Area and Its Competitors Table 148. GlaxoSmithKline Autoimmune Disease Drugs Product Portfolios and Specifications Table 149. GlaxoSmithKline Autoimmune Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 150. GlaxoSmithKline Main Business Table 151. GlaxoSmithKline Latest Developments Table 152. Johnson & Johnson Basic Information, Autoimmune Disease Drugs Manufacturing Base, Sales Area and Its Competitors Table 153. Johnson & Johnson Autoimmune Disease Drugs Product Portfolios and Specifications Table 154. Johnson & Johnson Autoimmune Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 155. Johnson & Johnson Main Business Table 156. Johnson & Johnson Latest Developments Table 157. Merck Basic Information, Autoimmune Disease Drugs Manufacturing Base, Sales Area and Its Competitors Table 158. Merck Autoimmune Disease Drugs Product Portfolios and Specifications Table 159. Merck Autoimmune Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 160. Merck Main Business Table 161. Merck Latest Developments Table 162. Novartis AG Basic Information, Autoimmune Disease Drugs Manufacturing Base, Sales Area and Its Competitors Table 163. Novartis AG Autoimmune Disease Drugs Product Portfolios and Specifications Table 164. Novartis AG Autoimmune Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 165. Novartis AG Main Business Table 166. Novartis AG Latest Developments Table 167. Pfizer Basic Information, Autoimmune Disease Drugs Manufacturing Base, Sales Area and Its Competitors Table 168. Pfizer Autoimmune Disease Drugs Product Portfolios and Specifications Table 169. Pfizer Autoimmune Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 170. Pfizer Main Business Table 171. Pfizer Latest Developments Table 172. Roche Holding Basic Information, Autoimmune Disease Drugs Manufacturing Base, Sales Area and Its Competitors Table 173. Roche Holding Autoimmune Disease Drugs Product Portfolios and Specifications Table 174. Roche Holding Autoimmune Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 175. Roche Holding Main Business Table 176. Roche Holding Latest Developments Table 177. Sanofi S.A. Basic Information, Autoimmune Disease Drugs Manufacturing Base, Sales Area and Its Competitors Table 178. Sanofi S.A. Autoimmune Disease Drugs Product Portfolios and Specifications Table 179. Sanofi S.A. Autoimmune Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 180. Sanofi S.A. Main Business Table 181. Sanofi S.A. Latest Developments Table 182. Takeda Pharmaceutical Basic Information, Autoimmune Disease Drugs Manufacturing Base, Sales Area and Its Competitors Table 183. Takeda Pharmaceutical Autoimmune Disease Drugs Product Portfolios and Specifications Table 184. Takeda Pharmaceutical Autoimmune Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 185. Takeda Pharmaceutical Main Business Table 186. Takeda Pharmaceutical Latest Developments List of Figures Figure 1. Picture of Autoimmune Disease Drugs Figure 2. Autoimmune Disease Drugs Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global Autoimmune Disease Drugs Sales Growth Rate 2021-2032 (K Units) Figure 7. Global Autoimmune Disease Drugs Revenue Growth Rate 2021-2032 ($ millions) Figure 8. Autoimmune Disease Drugs Sales by Geographic Region (2021, 2025 & 2032) & ($ millions) Figure 9. Autoimmune Disease Drugs Sales Market Share by Country/Region (2025) Figure 10. Autoimmune Disease Drugs Sales Market Share by Country/Region (2021, 2025 & 2032) Figure 11. Product Picture of Biopharma Figure 12. Product Picture of Small Molecule Drug Figure 13. Global Autoimmune Disease Drugs Sales Market Share by Type in 2026 Figure 14. Global Autoimmune Disease Drugs Revenue Market Share by Type (2021-2026) Figure 15. Autoimmune Disease Drugs Consumed in Hospital Figure 16. Global Autoimmune Disease Drugs Market: Hospital (2021-2026) & (K Units) Figure 17. Autoimmune Disease Drugs Consumed in Clinic Figure 18. Global Autoimmune Disease Drugs Market: Clinic (2021-2026) & (K Units) Figure 19. Autoimmune Disease Drugs Consumed in Others Figure 20. Global Autoimmune Disease Drugs Market: Others (2021-2026) & (K Units) Figure 21. Global Autoimmune Disease Drugs Sale Market Share by Application (2025) Figure 22. Global Autoimmune Disease Drugs Revenue Market Share by Application in 2026 Figure 23. Autoimmune Disease Drugs Sales by Company in 2026 (K Units) Figure 24. Global Autoimmune Disease Drugs Sales Market Share by Company in 2026 Figure 25. Autoimmune Disease Drugs Revenue by Company in 2026 ($ millions) Figure 26. Global Autoimmune Disease Drugs Revenue Market Share by Company in 2026 Figure 27. Global Autoimmune Disease Drugs Sales Market Share by Geographic Region (2021-2026) Figure 28. Global Autoimmune Disease Drugs Revenue Market Share by Geographic Region in 2026 Figure 29. Americas Autoimmune Disease Drugs Sales 2021-2026 (K Units) Figure 30. Americas Autoimmune Disease Drugs Revenue 2021-2026 ($ millions) Figure 31. APAC Autoimmune Disease Drugs Sales 2021-2026 (K Units) Figure 32. APAC Autoimmune Disease Drugs Revenue 2021-2026 ($ millions) Figure 33. Europe Autoimmune Disease Drugs Sales 2021-2026 (K Units) Figure 34. Europe Autoimmune Disease Drugs Revenue 2021-2026 ($ millions) Figure 35. Middle East & Africa Autoimmune Disease Drugs Sales 2021-2026 (K Units) Figure 36. Middle East & Africa Autoimmune Disease Drugs Revenue 2021-2026 ($ millions) Figure 37. Americas Autoimmune Disease Drugs Sales Market Share by Country in 2026 Figure 38. Americas Autoimmune Disease Drugs Revenue Market Share by Country (2021-2026) Figure 39. Americas Autoimmune Disease Drugs Sales Market Share by Type (2021-2026) Figure 40. Americas Autoimmune Disease Drugs Sales Market Share by Application (2021-2026) Figure 41. United States Autoimmune Disease Drugs Revenue Growth 2021-2026 ($ millions) Figure 42. Canada Autoimmune Disease Drugs Revenue Growth 2021-2026 ($ millions) Figure 43. Mexico Autoimmune Disease Drugs Revenue Growth 2021-2026 ($ millions) Figure 44. Brazil Autoimmune Disease Drugs Revenue Growth 2021-2026 ($ millions) Figure 45. APAC Autoimmune Disease Drugs Sales Market Share by Region in 2026 Figure 46. APAC Autoimmune Disease Drugs Revenue Market Share by Region (2021-2026) Figure 47. APAC Autoimmune Disease Drugs Sales Market Share by Type (2021-2026) Figure 48. APAC Autoimmune Disease Drugs Sales Market Share by Application (2021-2026) Figure 49. China Autoimmune Disease Drugs Revenue Growth 2021-2026 ($ millions) Figure 50. Japan Autoimmune Disease Drugs Revenue Growth 2021-2026 ($ millions) Figure 51. South Korea Autoimmune Disease Drugs Revenue Growth 2021-2026 ($ millions) Figure 52. Southeast Asia Autoimmune Disease Drugs Revenue Growth 2021-2026 ($ millions) Figure 53. India Autoimmune Disease Drugs Revenue Growth 2021-2026 ($ millions) Figure 54. Australia Autoimmune Disease Drugs Revenue Growth 2021-2026 ($ millions) Figure 55. China Taiwan Autoimmune Disease Drugs Revenue Growth 2021-2026 ($ millions) Figure 56. Europe Autoimmune Disease Drugs Sales Market Share by Country in 2026 Figure 57. Europe Autoimmune Disease Drugs Revenue Market Share by Country (2021-2026) Figure 58. Europe Autoimmune Disease Drugs Sales Market Share by Type (2021-2026) Figure 59. Europe Autoimmune Disease Drugs Sales Market Share by Application (2021-2026) Figure 60. Germany Autoimmune Disease Drugs Revenue Growth 2021-2026 ($ millions) Figure 61. France Autoimmune Disease Drugs Revenue Growth 2021-2026 ($ millions) Figure 62. UK Autoimmune Disease Drugs Revenue Growth 2021-2026 ($ millions) Figure 63. Italy Autoimmune Disease Drugs Revenue Growth 2021-2026 ($ millions) Figure 64. Russia Autoimmune Disease Drugs Revenue Growth 2021-2026 ($ millions) Figure 65. Middle East & Africa Autoimmune Disease Drugs Sales Market Share by Country (2021-2026) Figure 66. Middle East & Africa Autoimmune Disease Drugs Sales Market Share by Type (2021-2026) Figure 67. Middle East & Africa Autoimmune Disease Drugs Sales Market Share by Application (2021-2026) Figure 68. Egypt Autoimmune Disease Drugs Revenue Growth 2021-2026 ($ millions) Figure 69. South Africa Autoimmune Disease Drugs Revenue Growth 2021-2026 ($ millions) Figure 70. Israel Autoimmune Disease Drugs Revenue Growth 2021-2026 ($ millions) Figure 71. Turkey Autoimmune Disease Drugs Revenue Growth 2021-2026 ($ millions) Figure 72. GCC Countries Autoimmune Disease Drugs Revenue Growth 2021-2026 ($ millions) Figure 73. Manufacturing Cost Structure Analysis of Autoimmune Disease Drugs in 2026 Figure 74. Manufacturing Process Analysis of Autoimmune Disease Drugs Figure 75. Industry Chain Structure of Autoimmune Disease Drugs Figure 76. Channels of Distribution Figure 77. Global Autoimmune Disease Drugs Sales Market Forecast by Region (2027-2032) Figure 78. Global Autoimmune Disease Drugs Revenue Market Share Forecast by Region (2027-2032) Figure 79. Global Autoimmune Disease Drugs Sales Market Share Forecast by Type (2027-2032) Figure 80. Global Autoimmune Disease Drugs Revenue Market Share Forecast by Type (2027-2032) Figure 81. Global Autoimmune Disease Drugs Sales Market Share Forecast by Application (2027-2032) Figure 82. Global Autoimmune Disease Drugs Revenue Market Share Forecast by Application (2027-2032)
SummaryThe global Autoimmune Disease Drugs market size is predicted to grow from US$ 144220 million in 2025 to US$ 185520 million in 2032; it is expected to grow at a CAGR of 3.7% from 2026 to 2032.Autoimmune Disease Drugs refer to a class of drugs used to treat autoimmune diseases that are caused by the immune system mistakenly attacking the body's own tissues. These drugs are designed to regulate or suppress an overactive immune response to reduce symptoms, slow disease progression, and help patients maintain a normal quality of life. Common autoimmune disease drugs include anti-inflammatory drugs, immunosuppressants, biologics, etc., which act on the immune system through different mechanisms to control the condition and reduce damage to the body. Global key Autoimmune Disease Drugs players cover Qyuns Therapeutics, Bio-Thera Solutions, Hengrui Pharmaceuticals, Hisun Pharmaceutical, Sunshine Guojian Pharmaceutical, etc. Report Scope LP Information, Inc. (LPI) ' newest research report, the “Autoimmune Disease Drugs Industry Forecast” looks at past sales and reviews total world Autoimmune Disease Drugs sales in 2025, providing a comprehensive analysis by region and market sector of projected Autoimmune Disease Drugs sales for 2026 through 2032. With Autoimmune Disease Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Autoimmune Disease Drugs industry. This Insight Report provides a comprehensive analysis of the global Autoimmune Disease Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Autoimmune Disease Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Autoimmune Disease Drugs market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Autoimmune Disease Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Autoimmune Disease Drugs. This report presents a comprehensive overview, market shares, and growth opportunities of Autoimmune Disease Drugs market by product type, application, key manufacturers and key regions and countries. Market Segmentation Segmentation by Type: Biopharma Small Molecule Drug Segmentation by Application: Hospital Clinic Others This report also splits the market by region: Americas United States Canada Mexico Brazil APAC China Japan Korea Southeast Asia India Australia Europe Germany France UK Italy Russia Middle East & Africa Egypt South Africa Israel Turkey GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration. Qyuns Therapeutics Bio-Thera Solutions Hengrui Pharmaceuticals Hisun Pharmaceutical Sunshine Guojian Pharmaceutical Chia Tai Tianqing Pharmaceutical Chongqing Genrix Biopharmaceutical Keymed Biosciences Junshi Biosciences Akeso AbbVie AstraZeneca Biogen Bristol Myers Squibb Eli Lilly GlaxoSmithKline Johnson & Johnson Merck Novartis AG Pfizer Roche Holding Sanofi S.A. Takeda Pharmaceutical Key Questions Addressed in this Report What is the 10-year outlook for the global Autoimmune Disease Drugs market? What factors are driving Autoimmune Disease Drugs market growth, globally and by region? Which technologies are poised for the fastest growth by market and region? How do Autoimmune Disease Drugs market opportunities vary by end market size? How does Autoimmune Disease Drugs break out by Type, by Application? Table of Contents1 Scope of the Report1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Autoimmune Disease Drugs Annual Sales 2021-2032 2.1.2 World Current & Future Analysis for Autoimmune Disease Drugs by Geographic Region, 2021, 2025 & 2032 2.1.3 World Current & Future Analysis for Autoimmune Disease Drugs by Country/Region, 2021, 2025 & 2032 2.2 Autoimmune Disease Drugs Segment by Type 2.2.1 Biopharma 2.2.2 Small Molecule Drug 2.2.3 Autoimmune Disease Drugs Sales by Type 2.2.3.1 Global Autoimmune Disease Drugs Sales Market Share by Type (2021-2026) 2.2.3.2 Global Autoimmune Disease Drugs Revenue and Market Share by Type (2021-2026) 2.2.3.3 Global Autoimmune Disease Drugs Sale Price by Type (2021-2026) 2.3 Autoimmune Disease Drugs Segment by Application 2.3.1 Hospital 2.3.2 Clinic 2.3.3 Others 2.3.4 Autoimmune Disease Drugs Sales by Application 2.3.4.1 Global Autoimmune Disease Drugs Sale Market Share by Application (2021-2026) 2.3.4.2 Global Autoimmune Disease Drugs Revenue and Market Share by Application (2021-2026) 2.3.4.3 Global Autoimmune Disease Drugs Sale Price by Application (2021-2026) 3 Global by Company 3.1 Global Autoimmune Disease Drugs Breakdown Data by Company 3.1.1 Global Autoimmune Disease Drugs Annual Sales by Company (2021-2026) 3.1.2 Global Autoimmune Disease Drugs Sales Market Share by Company (2021-2026) 3.2 Global Autoimmune Disease Drugs Annual Revenue by Company (2021-2026) 3.2.1 Global Autoimmune Disease Drugs Revenue by Company (2021-2026) 3.2.2 Global Autoimmune Disease Drugs Revenue Market Share by Company (2021-2026) 3.3 Global Autoimmune Disease Drugs Sale Price by Company 3.4 Key Manufacturers Autoimmune Disease Drugs Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers Autoimmune Disease Drugs Product Location Distribution 3.4.2 Players Autoimmune Disease Drugs Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026) 3.6 New Products and Potential Entrants 3.7 Market M&A Activity & Strategy 4 World Historic Review for Autoimmune Disease Drugs by Geographic Region 4.1 World Historic Autoimmune Disease Drugs Market Size by Geographic Region (2021-2026) 4.1.1 Global Autoimmune Disease Drugs Annual Sales by Geographic Region (2021-2026) 4.1.2 Global Autoimmune Disease Drugs Annual Revenue by Geographic Region (2021-2026) 4.2 World Historic Autoimmune Disease Drugs Market Size by Country/Region (2021-2026) 4.2.1 Global Autoimmune Disease Drugs Annual Sales by Country/Region (2021-2026) 4.2.2 Global Autoimmune Disease Drugs Annual Revenue by Country/Region (2021-2026) 4.3 Americas Autoimmune Disease Drugs Sales Growth 4.4 APAC Autoimmune Disease Drugs Sales Growth 4.5 Europe Autoimmune Disease Drugs Sales Growth 4.6 Middle East & Africa Autoimmune Disease Drugs Sales Growth 5 Americas 5.1 Americas Autoimmune Disease Drugs Sales by Country 5.1.1 Americas Autoimmune Disease Drugs Sales by Country (2021-2026) 5.1.2 Americas Autoimmune Disease Drugs Revenue by Country (2021-2026) 5.2 Americas Autoimmune Disease Drugs Sales by Type (2021-2026) 5.3 Americas Autoimmune Disease Drugs Sales by Application (2021-2026) 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Autoimmune Disease Drugs Sales by Region 6.1.1 APAC Autoimmune Disease Drugs Sales by Region (2021-2026) 6.1.2 APAC Autoimmune Disease Drugs Revenue by Region (2021-2026) 6.2 APAC Autoimmune Disease Drugs Sales by Type (2021-2026) 6.3 APAC Autoimmune Disease Drugs Sales by Application (2021-2026) 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 6.10 China Taiwan 7 Europe 7.1 Europe Autoimmune Disease Drugs by Country 7.1.1 Europe Autoimmune Disease Drugs Sales by Country (2021-2026) 7.1.2 Europe Autoimmune Disease Drugs Revenue by Country (2021-2026) 7.2 Europe Autoimmune Disease Drugs Sales by Type (2021-2026) 7.3 Europe Autoimmune Disease Drugs Sales by Application (2021-2026) 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Autoimmune Disease Drugs by Country 8.1.1 Middle East & Africa Autoimmune Disease Drugs Sales by Country (2021-2026) 8.1.2 Middle East & Africa Autoimmune Disease Drugs Revenue by Country (2021-2026) 8.2 Middle East & Africa Autoimmune Disease Drugs Sales by Type (2021-2026) 8.3 Middle East & Africa Autoimmune Disease Drugs Sales by Application (2021-2026) 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Manufacturing Cost Structure Analysis 10.1 Raw Material and Suppliers 10.2 Manufacturing Cost Structure Analysis of Autoimmune Disease Drugs 10.3 Manufacturing Process Analysis of Autoimmune Disease Drugs 10.4 Industry Chain Structure of Autoimmune Disease Drugs 11 Marketing, Distributors and Customer 11.1 Sales Channel 11.1.1 Direct Channels 11.1.2 Indirect Channels 11.2 Autoimmune Disease Drugs Distributors 11.3 Autoimmune Disease Drugs Customer 12 World Forecast Review for Autoimmune Disease Drugs by Geographic Region 12.1 Global Autoimmune Disease Drugs Market Size Forecast by Region 12.1.1 Global Autoimmune Disease Drugs Forecast by Region (2027-2032) 12.1.2 Global Autoimmune Disease Drugs Annual Revenue Forecast by Region (2027-2032) 12.2 Americas Forecast by Country (2027-2032) 12.3 APAC Forecast by Region (2027-2032) 12.4 Europe Forecast by Country (2027-2032) 12.5 Middle East & Africa Forecast by Country (2027-2032) 12.6 Global Autoimmune Disease Drugs Forecast by Type (2027-2032) 12.7 Global Autoimmune Disease Drugs Forecast by Application (2027-2032) 13 Key Players Analysis 13.1 Qyuns Therapeutics 13.1.1 Qyuns Therapeutics Company Information 13.1.2 Qyuns Therapeutics Autoimmune Disease Drugs Product Portfolios and Specifications 13.1.3 Qyuns Therapeutics Autoimmune Disease Drugs Sales, Revenue, Price and Gross Margin (2021-2026) 13.1.4 Qyuns Therapeutics Main Business Overview 13.1.5 Qyuns Therapeutics Latest Developments 13.2 Bio-Thera Solutions 13.2.1 Bio-Thera Solutions Company Information 13.2.2 Bio-Thera Solutions Autoimmune Disease Drugs Product Portfolios and Specifications 13.2.3 Bio-Thera Solutions Autoimmune Disease Drugs Sales, Revenue, Price and Gross Margin (2021-2026) 13.2.4 Bio-Thera Solutions Main Business Overview 13.2.5 Bio-Thera Solutions Latest Developments 13.3 Hengrui Pharmaceuticals 13.3.1 Hengrui Pharmaceuticals Company Information 13.3.2 Hengrui Pharmaceuticals Autoimmune Disease Drugs Product Portfolios and Specifications 13.3.3 Hengrui Pharmaceuticals Autoimmune Disease Drugs Sales, Revenue, Price and Gross Margin (2021-2026) 13.3.4 Hengrui Pharmaceuticals Main Business Overview 13.3.5 Hengrui Pharmaceuticals Latest Developments 13.4 Hisun Pharmaceutical 13.4.1 Hisun Pharmaceutical Company Information 13.4.2 Hisun Pharmaceutical Autoimmune Disease Drugs Product Portfolios and Specifications 13.4.3 Hisun Pharmaceutical Autoimmune Disease Drugs Sales, Revenue, Price and Gross Margin (2021-2026) 13.4.4 Hisun Pharmaceutical Main Business Overview 13.4.5 Hisun Pharmaceutical Latest Developments 13.5 Sunshine Guojian Pharmaceutical 13.5.1 Sunshine Guojian Pharmaceutical Company Information 13.5.2 Sunshine Guojian Pharmaceutical Autoimmune Disease Drugs Product Portfolios and Specifications 13.5.3 Sunshine Guojian Pharmaceutical Autoimmune Disease Drugs Sales, Revenue, Price and Gross Margin (2021-2026) 13.5.4 Sunshine Guojian Pharmaceutical Main Business Overview 13.5.5 Sunshine Guojian Pharmaceutical Latest Developments 13.6 Chia Tai Tianqing Pharmaceutical 13.6.1 Chia Tai Tianqing Pharmaceutical Company Information 13.6.2 Chia Tai Tianqing Pharmaceutical Autoimmune Disease Drugs Product Portfolios and Specifications 13.6.3 Chia Tai Tianqing Pharmaceutical Autoimmune Disease Drugs Sales, Revenue, Price and Gross Margin (2021-2026) 13.6.4 Chia Tai Tianqing Pharmaceutical Main Business Overview 13.6.5 Chia Tai Tianqing Pharmaceutical Latest Developments 13.7 Chongqing Genrix Biopharmaceutical 13.7.1 Chongqing Genrix Biopharmaceutical Company Information 13.7.2 Chongqing Genrix Biopharmaceutical Autoimmune Disease Drugs Product Portfolios and Specifications 13.7.3 Chongqing Genrix Biopharmaceutical Autoimmune Disease Drugs Sales, Revenue, Price and Gross Margin (2021-2026) 13.7.4 Chongqing Genrix Biopharmaceutical Main Business Overview 13.7.5 Chongqing Genrix Biopharmaceutical Latest Developments 13.8 Keymed Biosciences 13.8.1 Keymed Biosciences Company Information 13.8.2 Keymed Biosciences Autoimmune Disease Drugs Product Portfolios and Specifications 13.8.3 Keymed Biosciences Autoimmune Disease Drugs Sales, Revenue, Price and Gross Margin (2021-2026) 13.8.4 Keymed Biosciences Main Business Overview 13.8.5 Keymed Biosciences Latest Developments 13.9 Junshi Biosciences 13.9.1 Junshi Biosciences Company Information 13.9.2 Junshi Biosciences Autoimmune Disease Drugs Product Portfolios and Specifications 13.9.3 Junshi Biosciences Autoimmune Disease Drugs Sales, Revenue, Price and Gross Margin (2021-2026) 13.9.4 Junshi Biosciences Main Business Overview 13.9.5 Junshi Biosciences Latest Developments 13.10 Akeso 13.10.1 Akeso Company Information 13.10.2 Akeso Autoimmune Disease Drugs Product Portfolios and Specifications 13.10.3 Akeso Autoimmune Disease Drugs Sales, Revenue, Price and Gross Margin (2021-2026) 13.10.4 Akeso Main Business Overview 13.10.5 Akeso Latest Developments 13.11 AbbVie 13.11.1 AbbVie Company Information 13.11.2 AbbVie Autoimmune Disease Drugs Product Portfolios and Specifications 13.11.3 AbbVie Autoimmune Disease Drugs Sales, Revenue, Price and Gross Margin (2021-2026) 13.11.4 AbbVie Main Business Overview 13.11.5 AbbVie Latest Developments 13.12 AstraZeneca 13.12.1 AstraZeneca Company Information 13.12.2 AstraZeneca Autoimmune Disease Drugs Product Portfolios and Specifications 13.12.3 AstraZeneca Autoimmune Disease Drugs Sales, Revenue, Price and Gross Margin (2021-2026) 13.12.4 AstraZeneca Main Business Overview 13.12.5 AstraZeneca Latest Developments 13.13 Biogen 13.13.1 Biogen Company Information 13.13.2 Biogen Autoimmune Disease Drugs Product Portfolios and Specifications 13.13.3 Biogen Autoimmune Disease Drugs Sales, Revenue, Price and Gross Margin (2021-2026) 13.13.4 Biogen Main Business Overview 13.13.5 Biogen Latest Developments 13.14 Bristol Myers Squibb 13.14.1 Bristol Myers Squibb Company Information 13.14.2 Bristol Myers Squibb Autoimmune Disease Drugs Product Portfolios and Specifications 13.14.3 Bristol Myers Squibb Autoimmune Disease Drugs Sales, Revenue, Price and Gross Margin (2021-2026) 13.14.4 Bristol Myers Squibb Main Business Overview 13.14.5 Bristol Myers Squibb Latest Developments 13.15 Eli Lilly 13.15.1 Eli Lilly Company Information 13.15.2 Eli Lilly Autoimmune Disease Drugs Product Portfolios and Specifications 13.15.3 Eli Lilly Autoimmune Disease Drugs Sales, Revenue, Price and Gross Margin (2021-2026) 13.15.4 Eli Lilly Main Business Overview 13.15.5 Eli Lilly Latest Developments 13.16 GlaxoSmithKline 13.16.1 GlaxoSmithKline Company Information 13.16.2 GlaxoSmithKline Autoimmune Disease Drugs Product Portfolios and Specifications 13.16.3 GlaxoSmithKline Autoimmune Disease Drugs Sales, Revenue, Price and Gross Margin (2021-2026) 13.16.4 GlaxoSmithKline Main Business Overview 13.16.5 GlaxoSmithKline Latest Developments 13.17 Johnson & Johnson 13.17.1 Johnson & Johnson Company Information 13.17.2 Johnson & Johnson Autoimmune Disease Drugs Product Portfolios and Specifications 13.17.3 Johnson & Johnson Autoimmune Disease Drugs Sales, Revenue, Price and Gross Margin (2021-2026) 13.17.4 Johnson & Johnson Main Business Overview 13.17.5 Johnson & Johnson Latest Developments 13.18 Merck 13.18.1 Merck Company Information 13.18.2 Merck Autoimmune Disease Drugs Product Portfolios and Specifications 13.18.3 Merck Autoimmune Disease Drugs Sales, Revenue, Price and Gross Margin (2021-2026) 13.18.4 Merck Main Business Overview 13.18.5 Merck Latest Developments 13.19 Novartis AG 13.19.1 Novartis AG Company Information 13.19.2 Novartis AG Autoimmune Disease Drugs Product Portfolios and Specifications 13.19.3 Novartis AG Autoimmune Disease Drugs Sales, Revenue, Price and Gross Margin (2021-2026) 13.19.4 Novartis AG Main Business Overview 13.19.5 Novartis AG Latest Developments 13.20 Pfizer 13.20.1 Pfizer Company Information 13.20.2 Pfizer Autoimmune Disease Drugs Product Portfolios and Specifications 13.20.3 Pfizer Autoimmune Disease Drugs Sales, Revenue, Price and Gross Margin (2021-2026) 13.20.4 Pfizer Main Business Overview 13.20.5 Pfizer Latest Developments 13.21 Roche Holding 13.21.1 Roche Holding Company Information 13.21.2 Roche Holding Autoimmune Disease Drugs Product Portfolios and Specifications 13.21.3 Roche Holding Autoimmune Disease Drugs Sales, Revenue, Price and Gross Margin (2021-2026) 13.21.4 Roche Holding Main Business Overview 13.21.5 Roche Holding Latest Developments 13.22 Sanofi S.A. 13.22.1 Sanofi S.A. Company Information 13.22.2 Sanofi S.A. Autoimmune Disease Drugs Product Portfolios and Specifications 13.22.3 Sanofi S.A. Autoimmune Disease Drugs Sales, Revenue, Price and Gross Margin (2021-2026) 13.22.4 Sanofi S.A. Main Business Overview 13.22.5 Sanofi S.A. Latest Developments 13.23 Takeda Pharmaceutical 13.23.1 Takeda Pharmaceutical Company Information 13.23.2 Takeda Pharmaceutical Autoimmune Disease Drugs Product Portfolios and Specifications 13.23.3 Takeda Pharmaceutical Autoimmune Disease Drugs Sales, Revenue, Price and Gross Margin (2021-2026) 13.23.4 Takeda Pharmaceutical Main Business Overview 13.23.5 Takeda Pharmaceutical Latest Developments 14 Research Findings and Conclusion List of Tables/GraphsList of TablesTable 1. Autoimmune Disease Drugs Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions) Table 2. Autoimmune Disease Drugs Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions) Table 3. Major Players of Biopharma Table 4. Major Players of Small Molecule Drug Table 5. Global Autoimmune Disease Drugs Sales by Type (2021-2026) & (K Units) Table 6. Global Autoimmune Disease Drugs Sales Market Share by Type (2021-2026) Table 7. Global Autoimmune Disease Drugs Revenue by Type (2021-2026) & ($ million) Table 8. Global Autoimmune Disease Drugs Revenue Market Share by Type (2021-2026) Table 9. Global Autoimmune Disease Drugs Sale Price by Type (2021-2026) & (US$/Unit) Table 10. Global Autoimmune Disease Drugs Sale by Application (2021-2026) & (K Units) Table 11. Global Autoimmune Disease Drugs Sale Market Share by Application (2021-2026) Table 12. Global Autoimmune Disease Drugs Revenue by Application (2021-2026) & ($ million) Table 13. Global Autoimmune Disease Drugs Revenue Market Share by Application (2021-2026) Table 14. Global Autoimmune Disease Drugs Sale Price by Application (2021-2026) & (US$/Unit) Table 15. Global Autoimmune Disease Drugs Sales by Company (2021-2026) & (K Units) Table 16. Global Autoimmune Disease Drugs Sales Market Share by Company (2021-2026) Table 17. Global Autoimmune Disease Drugs Revenue by Company (2021-2026) & ($ millions) Table 18. Global Autoimmune Disease Drugs Revenue Market Share by Company (2021-2026) Table 19. Global Autoimmune Disease Drugs Sale Price by Company (2021-2026) & (US$/Unit) Table 20. Key Manufacturers Autoimmune Disease Drugs Producing Area Distribution and Sales Area Table 21. Players Autoimmune Disease Drugs Products Offered Table 22. Autoimmune Disease Drugs Concentration Ratio (CR3, CR5 and CR10) & (2024-2026) Table 23. New Products and Potential Entrants Table 24. Market M&A Activity & Strategy Table 25. Global Autoimmune Disease Drugs Sales by Geographic Region (2021-2026) & (K Units) Table 26. Global Autoimmune Disease Drugs Sales Market Share Geographic Region (2021-2026) Table 27. Global Autoimmune Disease Drugs Revenue by Geographic Region (2021-2026) & ($ millions) Table 28. Global Autoimmune Disease Drugs Revenue Market Share by Geographic Region (2021-2026) Table 29. Global Autoimmune Disease Drugs Sales by Country/Region (2021-2026) & (K Units) Table 30. Global Autoimmune Disease Drugs Sales Market Share by Country/Region (2021-2026) Table 31. Global Autoimmune Disease Drugs Revenue by Country/Region (2021-2026) & ($ millions) Table 32. Global Autoimmune Disease Drugs Revenue Market Share by Country/Region (2021-2026) Table 33. Americas Autoimmune Disease Drugs Sales by Country (2021-2026) & (K Units) Table 34. Americas Autoimmune Disease Drugs Sales Market Share by Country (2021-2026) Table 35. Americas Autoimmune Disease Drugs Revenue by Country (2021-2026) & ($ millions) Table 36. Americas Autoimmune Disease Drugs Sales by Type (2021-2026) & (K Units) Table 37. Americas Autoimmune Disease Drugs Sales by Application (2021-2026) & (K Units) Table 38. APAC Autoimmune Disease Drugs Sales by Region (2021-2026) & (K Units) Table 39. APAC Autoimmune Disease Drugs Sales Market Share by Region (2021-2026) Table 40. APAC Autoimmune Disease Drugs Revenue by Region (2021-2026) & ($ millions) Table 41. APAC Autoimmune Disease Drugs Sales by Type (2021-2026) & (K Units) Table 42. APAC Autoimmune Disease Drugs Sales by Application (2021-2026) & (K Units) Table 43. Europe Autoimmune Disease Drugs Sales by Country (2021-2026) & (K Units) Table 44. Europe Autoimmune Disease Drugs Revenue by Country (2021-2026) & ($ millions) Table 45. Europe Autoimmune Disease Drugs Sales by Type (2021-2026) & (K Units) Table 46. Europe Autoimmune Disease Drugs Sales by Application (2021-2026) & (K Units) Table 47. Middle East & Africa Autoimmune Disease Drugs Sales by Country (2021-2026) & (K Units) Table 48. Middle East & Africa Autoimmune Disease Drugs Revenue Market Share by Country (2021-2026) Table 49. Middle East & Africa Autoimmune Disease Drugs Sales by Type (2021-2026) & (K Units) Table 50. Middle East & Africa Autoimmune Disease Drugs Sales by Application (2021-2026) & (K Units) Table 51. Key Market Drivers & Growth Opportunities of Autoimmune Disease Drugs Table 52. Key Market Challenges & Risks of Autoimmune Disease Drugs Table 53. Key Industry Trends of Autoimmune Disease Drugs Table 54. Autoimmune Disease Drugs Raw Material Table 55. Key Suppliers of Raw Materials Table 56. Autoimmune Disease Drugs Distributors List Table 57. Autoimmune Disease Drugs Customer List Table 58. Global Autoimmune Disease Drugs Sales Forecast by Region (2027-2032) & (K Units) Table 59. Global Autoimmune Disease Drugs Revenue Forecast by Region (2027-2032) & ($ millions) Table 60. Americas Autoimmune Disease Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 61. Americas Autoimmune Disease Drugs Annual Revenue Forecast by Country (2027-2032) & ($ millions) Table 62. APAC Autoimmune Disease Drugs Sales Forecast by Region (2027-2032) & (K Units) Table 63. APAC Autoimmune Disease Drugs Annual Revenue Forecast by Region (2027-2032) & ($ millions) Table 64. Europe Autoimmune Disease Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 65. Europe Autoimmune Disease Drugs Revenue Forecast by Country (2027-2032) & ($ millions) Table 66. Middle East & Africa Autoimmune Disease Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 67. Middle East & Africa Autoimmune Disease Drugs Revenue Forecast by Country (2027-2032) & ($ millions) Table 68. Global Autoimmune Disease Drugs Sales Forecast by Type (2027-2032) & (K Units) Table 69. Global Autoimmune Disease Drugs Revenue Forecast by Type (2027-2032) & ($ millions) Table 70. Global Autoimmune Disease Drugs Sales Forecast by Application (2027-2032) & (K Units) Table 71. Global Autoimmune Disease Drugs Revenue Forecast by Application (2027-2032) & ($ millions) Table 72. Qyuns Therapeutics Basic Information, Autoimmune Disease Drugs Manufacturing Base, Sales Area and Its Competitors Table 73. Qyuns Therapeutics Autoimmune Disease Drugs Product Portfolios and Specifications Table 74. Qyuns Therapeutics Autoimmune Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Qyuns Therapeutics Main Business Table 76. Qyuns Therapeutics Latest Developments Table 77. Bio-Thera Solutions Basic Information, Autoimmune Disease Drugs Manufacturing Base, Sales Area and Its Competitors Table 78. Bio-Thera Solutions Autoimmune Disease Drugs Product Portfolios and Specifications Table 79. Bio-Thera Solutions Autoimmune Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Bio-Thera Solutions Main Business Table 81. Bio-Thera Solutions Latest Developments Table 82. Hengrui Pharmaceuticals Basic Information, Autoimmune Disease Drugs Manufacturing Base, Sales Area and Its Competitors Table 83. Hengrui Pharmaceuticals Autoimmune Disease Drugs Product Portfolios and Specifications Table 84. Hengrui Pharmaceuticals Autoimmune Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Hengrui Pharmaceuticals Main Business Table 86. Hengrui Pharmaceuticals Latest Developments Table 87. Hisun Pharmaceutical Basic Information, Autoimmune Disease Drugs Manufacturing Base, Sales Area and Its Competitors Table 88. Hisun Pharmaceutical Autoimmune Disease Drugs Product Portfolios and Specifications Table 89. Hisun Pharmaceutical Autoimmune Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Hisun Pharmaceutical Main Business Table 91. Hisun Pharmaceutical Latest Developments Table 92. Sunshine Guojian Pharmaceutical Basic Information, Autoimmune Disease Drugs Manufacturing Base, Sales Area and Its Competitors Table 93. Sunshine Guojian Pharmaceutical Autoimmune Disease Drugs Product Portfolios and Specifications Table 94. Sunshine Guojian Pharmaceutical Autoimmune Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Sunshine Guojian Pharmaceutical Main Business Table 96. Sunshine Guojian Pharmaceutical Latest Developments Table 97. Chia Tai Tianqing Pharmaceutical Basic Information, Autoimmune Disease Drugs Manufacturing Base, Sales Area and Its Competitors Table 98. Chia Tai Tianqing Pharmaceutical Autoimmune Disease Drugs Product Portfolios and Specifications Table 99. Chia Tai Tianqing Pharmaceutical Autoimmune Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Chia Tai Tianqing Pharmaceutical Main Business Table 101. Chia Tai Tianqing Pharmaceutical Latest Developments Table 102. Chongqing Genrix Biopharmaceutical Basic Information, Autoimmune Disease Drugs Manufacturing Base, Sales Area and Its Competitors Table 103. Chongqing Genrix Biopharmaceutical Autoimmune Disease Drugs Product Portfolios and Specifications Table 104. Chongqing Genrix Biopharmaceutical Autoimmune Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Chongqing Genrix Biopharmaceutical Main Business Table 106. Chongqing Genrix Biopharmaceutical Latest Developments Table 107. Keymed Biosciences Basic Information, Autoimmune Disease Drugs Manufacturing Base, Sales Area and Its Competitors Table 108. Keymed Biosciences Autoimmune Disease Drugs Product Portfolios and Specifications Table 109. Keymed Biosciences Autoimmune Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Keymed Biosciences Main Business Table 111. Keymed Biosciences Latest Developments Table 112. Junshi Biosciences Basic Information, Autoimmune Disease Drugs Manufacturing Base, Sales Area and Its Competitors Table 113. Junshi Biosciences Autoimmune Disease Drugs Product Portfolios and Specifications Table 114. Junshi Biosciences Autoimmune Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Junshi Biosciences Main Business Table 116. Junshi Biosciences Latest Developments Table 117. Akeso Basic Information, Autoimmune Disease Drugs Manufacturing Base, Sales Area and Its Competitors Table 118. Akeso Autoimmune Disease Drugs Product Portfolios and Specifications Table 119. Akeso Autoimmune Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Akeso Main Business Table 121. Akeso Latest Developments Table 122. AbbVie Basic Information, Autoimmune Disease Drugs Manufacturing Base, Sales Area and Its Competitors Table 123. AbbVie Autoimmune Disease Drugs Product Portfolios and Specifications Table 124. AbbVie Autoimmune Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. AbbVie Main Business Table 126. AbbVie Latest Developments Table 127. AstraZeneca Basic Information, Autoimmune Disease Drugs Manufacturing Base, Sales Area and Its Competitors Table 128. AstraZeneca Autoimmune Disease Drugs Product Portfolios and Specifications Table 129. AstraZeneca Autoimmune Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. AstraZeneca Main Business Table 131. AstraZeneca Latest Developments Table 132. Biogen Basic Information, Autoimmune Disease Drugs Manufacturing Base, Sales Area and Its Competitors Table 133. Biogen Autoimmune Disease Drugs Product Portfolios and Specifications Table 134. Biogen Autoimmune Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 135. Biogen Main Business Table 136. Biogen Latest Developments Table 137. Bristol Myers Squibb Basic Information, Autoimmune Disease Drugs Manufacturing Base, Sales Area and Its Competitors Table 138. Bristol Myers Squibb Autoimmune Disease Drugs Product Portfolios and Specifications Table 139. Bristol Myers Squibb Autoimmune Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 140. Bristol Myers Squibb Main Business Table 141. Bristol Myers Squibb Latest Developments Table 142. Eli Lilly Basic Information, Autoimmune Disease Drugs Manufacturing Base, Sales Area and Its Competitors Table 143. Eli Lilly Autoimmune Disease Drugs Product Portfolios and Specifications Table 144. Eli Lilly Autoimmune Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 145. Eli Lilly Main Business Table 146. Eli Lilly Latest Developments Table 147. GlaxoSmithKline Basic Information, Autoimmune Disease Drugs Manufacturing Base, Sales Area and Its Competitors Table 148. GlaxoSmithKline Autoimmune Disease Drugs Product Portfolios and Specifications Table 149. GlaxoSmithKline Autoimmune Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 150. GlaxoSmithKline Main Business Table 151. GlaxoSmithKline Latest Developments Table 152. Johnson & Johnson Basic Information, Autoimmune Disease Drugs Manufacturing Base, Sales Area and Its Competitors Table 153. Johnson & Johnson Autoimmune Disease Drugs Product Portfolios and Specifications Table 154. Johnson & Johnson Autoimmune Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 155. Johnson & Johnson Main Business Table 156. Johnson & Johnson Latest Developments Table 157. Merck Basic Information, Autoimmune Disease Drugs Manufacturing Base, Sales Area and Its Competitors Table 158. Merck Autoimmune Disease Drugs Product Portfolios and Specifications Table 159. Merck Autoimmune Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 160. Merck Main Business Table 161. Merck Latest Developments Table 162. Novartis AG Basic Information, Autoimmune Disease Drugs Manufacturing Base, Sales Area and Its Competitors Table 163. Novartis AG Autoimmune Disease Drugs Product Portfolios and Specifications Table 164. Novartis AG Autoimmune Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 165. Novartis AG Main Business Table 166. Novartis AG Latest Developments Table 167. Pfizer Basic Information, Autoimmune Disease Drugs Manufacturing Base, Sales Area and Its Competitors Table 168. Pfizer Autoimmune Disease Drugs Product Portfolios and Specifications Table 169. Pfizer Autoimmune Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 170. Pfizer Main Business Table 171. Pfizer Latest Developments Table 172. Roche Holding Basic Information, Autoimmune Disease Drugs Manufacturing Base, Sales Area and Its Competitors Table 173. Roche Holding Autoimmune Disease Drugs Product Portfolios and Specifications Table 174. Roche Holding Autoimmune Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 175. Roche Holding Main Business Table 176. Roche Holding Latest Developments Table 177. Sanofi S.A. Basic Information, Autoimmune Disease Drugs Manufacturing Base, Sales Area and Its Competitors Table 178. Sanofi S.A. Autoimmune Disease Drugs Product Portfolios and Specifications Table 179. Sanofi S.A. Autoimmune Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 180. Sanofi S.A. Main Business Table 181. Sanofi S.A. Latest Developments Table 182. Takeda Pharmaceutical Basic Information, Autoimmune Disease Drugs Manufacturing Base, Sales Area and Its Competitors Table 183. Takeda Pharmaceutical Autoimmune Disease Drugs Product Portfolios and Specifications Table 184. Takeda Pharmaceutical Autoimmune Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 185. Takeda Pharmaceutical Main Business Table 186. Takeda Pharmaceutical Latest Developments List of Figures Figure 1. Picture of Autoimmune Disease Drugs Figure 2. Autoimmune Disease Drugs Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global Autoimmune Disease Drugs Sales Growth Rate 2021-2032 (K Units) Figure 7. Global Autoimmune Disease Drugs Revenue Growth Rate 2021-2032 ($ millions) Figure 8. Autoimmune Disease Drugs Sales by Geographic Region (2021, 2025 & 2032) & ($ millions) Figure 9. Autoimmune Disease Drugs Sales Market Share by Country/Region (2025) Figure 10. Autoimmune Disease Drugs Sales Market Share by Country/Region (2021, 2025 & 2032) Figure 11. Product Picture of Biopharma Figure 12. Product Picture of Small Molecule Drug Figure 13. Global Autoimmune Disease Drugs Sales Market Share by Type in 2026 Figure 14. Global Autoimmune Disease Drugs Revenue Market Share by Type (2021-2026) Figure 15. Autoimmune Disease Drugs Consumed in Hospital Figure 16. Global Autoimmune Disease Drugs Market: Hospital (2021-2026) & (K Units) Figure 17. Autoimmune Disease Drugs Consumed in Clinic Figure 18. Global Autoimmune Disease Drugs Market: Clinic (2021-2026) & (K Units) Figure 19. Autoimmune Disease Drugs Consumed in Others Figure 20. Global Autoimmune Disease Drugs Market: Others (2021-2026) & (K Units) Figure 21. Global Autoimmune Disease Drugs Sale Market Share by Application (2025) Figure 22. Global Autoimmune Disease Drugs Revenue Market Share by Application in 2026 Figure 23. Autoimmune Disease Drugs Sales by Company in 2026 (K Units) Figure 24. Global Autoimmune Disease Drugs Sales Market Share by Company in 2026 Figure 25. Autoimmune Disease Drugs Revenue by Company in 2026 ($ millions) Figure 26. Global Autoimmune Disease Drugs Revenue Market Share by Company in 2026 Figure 27. Global Autoimmune Disease Drugs Sales Market Share by Geographic Region (2021-2026) Figure 28. Global Autoimmune Disease Drugs Revenue Market Share by Geographic Region in 2026 Figure 29. Americas Autoimmune Disease Drugs Sales 2021-2026 (K Units) Figure 30. Americas Autoimmune Disease Drugs Revenue 2021-2026 ($ millions) Figure 31. APAC Autoimmune Disease Drugs Sales 2021-2026 (K Units) Figure 32. APAC Autoimmune Disease Drugs Revenue 2021-2026 ($ millions) Figure 33. Europe Autoimmune Disease Drugs Sales 2021-2026 (K Units) Figure 34. Europe Autoimmune Disease Drugs Revenue 2021-2026 ($ millions) Figure 35. Middle East & Africa Autoimmune Disease Drugs Sales 2021-2026 (K Units) Figure 36. Middle East & Africa Autoimmune Disease Drugs Revenue 2021-2026 ($ millions) Figure 37. Americas Autoimmune Disease Drugs Sales Market Share by Country in 2026 Figure 38. Americas Autoimmune Disease Drugs Revenue Market Share by Country (2021-2026) Figure 39. Americas Autoimmune Disease Drugs Sales Market Share by Type (2021-2026) Figure 40. Americas Autoimmune Disease Drugs Sales Market Share by Application (2021-2026) Figure 41. United States Autoimmune Disease Drugs Revenue Growth 2021-2026 ($ millions) Figure 42. Canada Autoimmune Disease Drugs Revenue Growth 2021-2026 ($ millions) Figure 43. Mexico Autoimmune Disease Drugs Revenue Growth 2021-2026 ($ millions) Figure 44. Brazil Autoimmune Disease Drugs Revenue Growth 2021-2026 ($ millions) Figure 45. APAC Autoimmune Disease Drugs Sales Market Share by Region in 2026 Figure 46. APAC Autoimmune Disease Drugs Revenue Market Share by Region (2021-2026) Figure 47. APAC Autoimmune Disease Drugs Sales Market Share by Type (2021-2026) Figure 48. APAC Autoimmune Disease Drugs Sales Market Share by Application (2021-2026) Figure 49. China Autoimmune Disease Drugs Revenue Growth 2021-2026 ($ millions) Figure 50. Japan Autoimmune Disease Drugs Revenue Growth 2021-2026 ($ millions) Figure 51. South Korea Autoimmune Disease Drugs Revenue Growth 2021-2026 ($ millions) Figure 52. Southeast Asia Autoimmune Disease Drugs Revenue Growth 2021-2026 ($ millions) Figure 53. India Autoimmune Disease Drugs Revenue Growth 2021-2026 ($ millions) Figure 54. Australia Autoimmune Disease Drugs Revenue Growth 2021-2026 ($ millions) Figure 55. China Taiwan Autoimmune Disease Drugs Revenue Growth 2021-2026 ($ millions) Figure 56. Europe Autoimmune Disease Drugs Sales Market Share by Country in 2026 Figure 57. Europe Autoimmune Disease Drugs Revenue Market Share by Country (2021-2026) Figure 58. Europe Autoimmune Disease Drugs Sales Market Share by Type (2021-2026) Figure 59. Europe Autoimmune Disease Drugs Sales Market Share by Application (2021-2026) Figure 60. Germany Autoimmune Disease Drugs Revenue Growth 2021-2026 ($ millions) Figure 61. France Autoimmune Disease Drugs Revenue Growth 2021-2026 ($ millions) Figure 62. UK Autoimmune Disease Drugs Revenue Growth 2021-2026 ($ millions) Figure 63. Italy Autoimmune Disease Drugs Revenue Growth 2021-2026 ($ millions) Figure 64. Russia Autoimmune Disease Drugs Revenue Growth 2021-2026 ($ millions) Figure 65. Middle East & Africa Autoimmune Disease Drugs Sales Market Share by Country (2021-2026) Figure 66. Middle East & Africa Autoimmune Disease Drugs Sales Market Share by Type (2021-2026) Figure 67. Middle East & Africa Autoimmune Disease Drugs Sales Market Share by Application (2021-2026) Figure 68. Egypt Autoimmune Disease Drugs Revenue Growth 2021-2026 ($ millions) Figure 69. South Africa Autoimmune Disease Drugs Revenue Growth 2021-2026 ($ millions) Figure 70. Israel Autoimmune Disease Drugs Revenue Growth 2021-2026 ($ millions) Figure 71. Turkey Autoimmune Disease Drugs Revenue Growth 2021-2026 ($ millions) Figure 72. GCC Countries Autoimmune Disease Drugs Revenue Growth 2021-2026 ($ millions) Figure 73. Manufacturing Cost Structure Analysis of Autoimmune Disease Drugs in 2026 Figure 74. Manufacturing Process Analysis of Autoimmune Disease Drugs Figure 75. Industry Chain Structure of Autoimmune Disease Drugs Figure 76. Channels of Distribution Figure 77. Global Autoimmune Disease Drugs Sales Market Forecast by Region (2027-2032) Figure 78. Global Autoimmune Disease Drugs Revenue Market Share Forecast by Region (2027-2032) Figure 79. Global Autoimmune Disease Drugs Sales Market Share Forecast by Type (2027-2032) Figure 80. Global Autoimmune Disease Drugs Revenue Market Share Forecast by Type (2027-2032) Figure 81. Global Autoimmune Disease Drugs Sales Market Share Forecast by Application (2027-2032) Figure 82. Global Autoimmune Disease Drugs Revenue Market Share Forecast by Application (2027-2032)
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（医薬）の最新刊レポート
LP Information社の 医薬品・ヘルスケア分野 での最新刊レポート
よくあるご質問LP Information社はどのような調査会社ですか?LP Informationは通信、エネルギー、医薬をはじめとする広範な市場の調査とレポート出版を行っている調査会社です。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
|
